Synthetic Biologics is a Maryland-based clinical-stage company that develops and commercializes microbiome therapeutics for the treatment of pertussis and infectious diseases.
Business Model:
Revenue: $800k
Employees: 11-50
Address: 9605 Medical Center Dr
City: Rockville
State: MD
Zip: 20850
Country: US
Synthetic Biologics is a Maryland-based clinical-stage company that develops and commercializes microbiome therapeutics for the treatment of pertussis and infectious diseases.
Contact Phone:
+13014174364
Contact Email:
Listed Exchange:
NYSE
IPO Date:
7/6/2007
Ticker Symbol:
SYN
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2015 | Post-IPO Equity | $46M | 3/2022 | Post-IPO Equity | $1.5M | 9/2017 | Post-IPO Equity | 1 | $12M |
MSD Partners MSD Partners |
10/2012 | Post-IPO Equity | 1 | $10.8M |
Randal J. Kirk Randal J. Kirk |
10/2018 | Post-IPO Equity | $18.6M | 9/2013 | Grant | 2 | $5.6M |
Biotechnology and Biological Sciences Research Council Engineering and Physical Sciences Research Council Biotechnology and Biological Sciences Research Council Engineering and Physical Sciences Research Council |
7/2022 | Post-IPO Equity | $3M |
---|
Announced Date | Name | Price |
---|---|---|
12/2021 | VCN Biosciences |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|